What do systematic reviews say?

Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB

• Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure 2024 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 440 participants
  Moderate

Summary of findings table ‐ Adjunctive therapies in addition to land‐based exercise therapy vs land‐based exercise therapy

• Adjunctive therapies in addition to land‐based exercise therapy for osteoarthritis of the hip or knee 2022 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 1483 participants
  Very low

Summary of findings: multimedia education and a co‐intervention vs co‐intervention alone

The review found no eligible studies for this question.

• Multimedia educational interventions for consumers about prescribed and over‐the‐counter medications 2013 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Off‐midline closure (Karydakis flap) vs off‐midline closure (Limberg flap)

The review found no eligible studies for this question.

• Midline and off‐midline wound closure methods after surgical treatment for pilonidal sinus 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Rifaximin vs non‐absorbable disaccharide

• Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 249 participants
  Very low

Summary of findings table ‐ Rifaximin vs placebo or no intervention

• Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 214 participants
  Moderate

Summary of findings ‐ triple therapy: elexacaftor‐tezacaftor‐ivacaftor vs control (ivacaftor alone or tezacaftor plus ivacaftor)

The review found no eligible studies for this question.

• Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings (water exercise vs no exercise

• Water‐based exercise training for chronic obstructive pulmonary disease 2013 · Cochrane Headline outcomes only
  no estimate extracted
  19 participants
  Low

Summary of findings for resveratrol plus oral anti‐diabetic drugs vs placebo plus oral anti‐diabetic drugs

The review found no eligible studies for this question.

• Resveratrol for adults with type 2 diabetes mellitus 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings (water exercise vs land exercise)

• Water‐based exercise training for chronic obstructive pulmonary disease 2013 · Cochrane Headline outcomes only
  no estimate extracted
  60 participants
  Low

Exercise vs usual care with or without sham interventions

• Exercise for acutely hospitalised older medical patients 2022 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 875 participants
  Low

Summary of findings: anti‐pseudomonal antibiotics vs placebo

• Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 245 participants
  Low

Summary of findings table ‐ Cognitive rehabilitation vs inactive control

• Cognitive rehabilitation for people with mild to moderate dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 783 participants
  Moderate

Summary of findings table ‐ Cognitive rehabilitation vs inactive control

• Cognitive rehabilitation for people with mild to moderate dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 853 participants
  Moderate

Summary of findings: insulin detemir vs NPH insulin

• (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 870 participants
  Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs usual pharmacological care alone

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs another intervention (education, joint aids, or relaxation) plus usual pharmacological care

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Systemic therapy vs control

• Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast… 2022 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 147 participants
  Very low

Summary of findings table ‐ Systemic therapy vs control

• Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast… 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 44 participants
  Low